Clinical diagnostics specialist Novacyt has appointed Paul Eros as its commercial director of Primerdesign, a role that will see him focus on building its business-to-business pipeline.
Following 30 years’ experience within the field of molecular diagnostics, including strategic global marketing, sales and product management, Eros joins the French group from DiaSorin, where he was vice president of molecular marketing.
Graham Mullis, Group CEO at Novacyt, said: “Paul’s considerable blue-chip commercial expertise specifically in molecular diagnostics will be hugely beneficial as we aim to convert our healthy pipeline of clinical projects and B2B opportunities into new contracts.
“I am confident that we have invested in a strong senior leadership team that can continue to drive growth from the many opportunities that we see.”
Eros completes Novacyt’s investment in its senior commercial leadership team, building on the earlier appointments of Ruth Powell as managing director of the NovaPrep division and Phil Sefton as managing director of LAB21 Products.